Given the critical importance of controlling AR activity for prostate cancer therapy, the present study provides the foundation for future investigations directed at dissecting the role of BPA and ERβ in controlling prostate cancer growth and/or progression. This evidence concerns the gene ESR2 and prostate cancer.